IDO T
Idogen about the conference in Boston and the plans ahead
Christina Herder, acting CEO of the biotechnology company Idogen, joined BioStock's studio to talk about the company's participation at the 6th...
Idogen one of ten companies selected for world-leading meeting
The biotechnology company Idogen was invited to participate on January 20-22...
Idogen strengthens fund for clinical study in 2023
The subscription period has now begun for Idogen's rights issue, which...
Idogen strengthens the board with Jan Holgersson
Idogen strengthens the board with Professor Jan Holgersson as...
Idogen's acting CEO comments on the share issue
Biotechnology company Idogen is in the clinical phase with...
Exciting times for Idogen's new chairman of the board
On September 6, an extraordinary general meeting was held in...
BioStock Investor Meeting: Interview with Idogen
In connection with the BioStock Investor Meeting in Stockholm...
Idogen's CMO on the transformation to clinical phase for IDO 8
Recently, the biotechnology company Idogen announced that the company has received...
Idogen's acting CEO talks about plans for the fall
hristina Herder has been appointed as the new acting CEO...
Idogen's study approved in Norway and Sweden
Idogen has now received the go-ahead from both the...
BioStock Studio: Idogen receives approval for Phase I/IIa study with IDO 8
Yesterday, the cell therapy company Idogen announced that the Swedish Medical Products Agency has approved its...
BioStock Studio: Idogen approaches clinical trial
Cell therapy company Idogen is approaching the start of a clinical...
Notes
iZafe takes the next step in the Nordics – begins Finnish partnership for Dosell
Senzime's partner receives FDA approval for TetraGraph module
Ellen sells the business for SEK 13,3 million
Oncopeptides increases sales in the second quarter
Alvotech acquires Ivers-Lee Group in Switzerland
NEWSLETTER
NEWS
Merck gears up in lung diseases with giant acquisition
AstraZeneca strengthens gene therapy portfolio with deals worth up to $825 million
AlzeCure Pharma: “We have good momentum”
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The EU's new life science strategy – a step in the right direction or just fluff?
Early signs of spring in an otherwise frosty biotech landscape
